Anti-Human BLys Therapeutic Antibody (Belimumab)
Recombinant monoclonal antibody to Human BLyS. Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). B cells are responsible for part of the normal immune response, and also for the over-aggressive immune response in autoimmune diseases like systemic lupus erythematosus (SLE).
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-030 |
| Pricing | Inquiry |
| Host | Human |
| Target | BLyS |
| Species Reactivity | Human |
| Type | IgG1 - lambda |
| Applications | Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods. |
| Storage | At -20°C for one year. |